These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 931406)

  • 1. Rifampin in leishmaniasis.
    Vásquez FR
    Arch Dermatol; 1977 Nov; 113(11):1610-1. PubMed ID: 931406
    [No Abstract]   [Full Text] [Related]  

  • 2. Dermal leishmaniasis after kala-azar infection: successful treatment with rifampin.
    Saha SK
    Cutis; 1985 Jul; 36(1):81-2. PubMed ID: 4017660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmaniasis: a case history and treatment failure with rifampin.
    White SW; Hendricks LD; Chulay JD
    Arch Dermatol; 1980 Jun; 116(6):620-1. PubMed ID: 7377797
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of rifampin therapy to cure cutaneous leishmaniais.
    Bygbjerg IC; Knudsen L; Kieffer M
    Arch Dermatol; 1980 Sep; 116(9):988. PubMed ID: 7416770
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermal leishmaniasis and rifampicin.
    Joshi RK; Nambiar PM
    Int J Dermatol; 1989 Nov; 28(9):612-4. PubMed ID: 2583909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin treatment of cutaneous leishmaniasis.
    Even-Paz Z; Weinrauch L; Livshin R; El-On J; Greenblatt CL
    Int J Dermatol; 1982 Mar; 21(2):110-2. PubMed ID: 7040263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of healing response by immunostimulant therapy (levamisole) in cutaneous leishmaniasis.
    Makled M; Rifaat M; Azab M; Makhlouf S; El-Missery A; Khalil N
    Chemioterapia; 1987 Jun; 6(2 Suppl):214-6. PubMed ID: 3509936
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of ketoconazole and a combination of rifampicin/amphotericin B on cutaneous leishmaniasis in laboratory mice.
    Weinrauch L; El-On J
    Trans R Soc Trop Med Hyg; 1984; 78(3):389-90. PubMed ID: 6087514
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of metronidazole in cutaneous leishmaniasis.
    Griffiths WA
    Arch Dermatol; 1976 Dec; 112(12):1791. PubMed ID: 1008576
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin in cutaneous leishmaniasis.
    Iskandar IO
    J Int Med Res; 1978; 6(4):280-5. PubMed ID: 689290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cutaneous leishmaniasis in Saudi Arabia.
    Fattah AA; Morsy TA; Ismail MA
    J Egypt Soc Parasitol; 1983 Jun; 13(1):9-17. PubMed ID: 6313824
    [No Abstract]   [Full Text] [Related]  

  • 12. The treatment of diffuse cutaneous leishmaniasis: a report of two cases.
    Okelo GB; Sang D; Bhatt KM
    East Afr Med J; 1991 Jan; 68(1):67-8. PubMed ID: 1647944
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cutaneous leishmaniasis: an autochtonous case in Switzerland?].
    Mazzi R
    Dermatologica; 1976; 153(2):104-5. PubMed ID: 1001590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis.
    Peters W; Lainson R; Shaw JJ; Robinson BL; Leão AF
    Lancet; 1981 May; 1(8230):1122-4. PubMed ID: 6112485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited therapeutic action of rifampicin/isoniazid against Leishmania aethiopica.
    van der Meulen J; Mock B; Fekete E; Sarojini PA
    Lancet; 1981 Jul; 2(8239):197-8. PubMed ID: 6114258
    [No Abstract]   [Full Text] [Related]  

  • 16. Visceral leishmaniasis treated with rifampicin and co-trimoxazole.
    Chatterjee S; Chatterjee R
    J Indian Med Assoc; 1994 Sep; 92(9):307. PubMed ID: 7814908
    [No Abstract]   [Full Text] [Related]  

  • 17. Visceral leishmaniasis treated with rifampicin and cotrimoxazole.
    Chatterjee S; Chatterjee R
    Indian Pediatr; 1993 May; 30(5):716-8. PubMed ID: 8282409
    [No Abstract]   [Full Text] [Related]  

  • 18. Recurrent cutaneous leishmaniasis: successful treatment with sodium antimony gluconate.
    Aram H; el-On J
    Cutis; 1986 Mar; 37(3):177-9. PubMed ID: 3007035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa otochondritis complicating localized cutaneous leishmaniasis: prevention of mutilation by early antibiotic therapy.
    Van Der Vliet D; Le Guern AS; Freitag S; Gounod N; Therby A; Darie H; Buffet PA
    Am J Trop Med Hyg; 2006 Aug; 75(2):270-2. PubMed ID: 16896131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic options for cutaneous leishmaniasis.
    Mahajan VK; Sharma NL
    J Dermatolog Treat; 2007; 18(2):97-104. PubMed ID: 17520466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.